USFDA classifies Solara's Cuddalore facility as Official Action Indicated

Image
Capital Market
Last Updated : Jun 23 2020 | 11:06 AM IST
Solara Active Pharma Sciences announced that the USFDA has classified its manufacturing site at Cuddalore, Tamil Nadu as Official Action Indicated(OAI). This outcome is based on the USFDA's inspection at the site between 2 March to 7 March 2020.

The reclassification of the Cuddalore site will not impact the business continuity for FY21. The Company continues to maintain its FY21 guidance both on the revenues and EBITDA.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 23 2020 | 10:41 AM IST

Next Story